Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.

Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry. Catheter Cardiovasc Interv. 2017 Jun 01; 89(7):E217-E225.

View in: PubMed

subject areas

Aged
Aged
Aspirin
Aspirin
Coronary Thrombosis
Coronary Thrombosis
Drug Administration Schedule
Drug Administration Schedule
Drug Antagonism
Drug Antagonism
Drug Therapy, Combination
Drug Therapy, Combination
Europe
Europe
Female
Female
Hemorrhage
Hemorrhage
Humans
Humans
Kaplan-Meier Estimate
Kaplan-Meier Estimate
Male
Male
Middle Aged
Middle Aged
Myocardial Infarction
Myocardial Infarction
Myocardial Ischemia
Myocardial Ischemia
Percutaneous Coronary Intervention
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Platelet Aggregation Inhibitors
Proportional Hazards Models
Proportional Hazards Models
Prospective Studies
Prospective Studies
Proton Pump Inhibitors
Proton Pump Inhibitors
Registries
Registries
Risk Factors
Risk Factors
Stents
Stents
Ticlopidine
Ticlopidine
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome
United States
United States

authors with profiles

Usman Baber